| Literature DB >> 24696663 |
Mohammad Songolzadeh1, Mansooreh Soleimani1, Maryam Takht Ravanchi2, Reza Songolzadeh3.
Abstract
Increasing concentrations of greenhouse gases (GHGs) such as CO2 in the atmosphere is a global warming. Human activities are a major cause of increased CO2 concentration in atmosphere, as in recent decade, two-third of greenhouse effect was caused by human activities. Carbon capture and storage (CCS) is a major strategy that can be used to reduce GHGs emission. There are three methods for CCS: pre-combustion capture, oxy-fuel process, and post-combustion capture. Among them, post-combustion capture is the most important one because it offers flexibility and it can be easily added to the operational units. Various technologies are used for CO2 capture, some of them include: absorption, adsorption, cryogenic distillation, and membrane separation. In this paper, various technologies for post-combustion are compared and the best condition for using each technology is identified.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24696663 PMCID: PMC3947793 DOI: 10.1155/2014/828131
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
The main greenhouse gases and their concentration [2, 3].
| Compound | Preindustrial concentration (ppmv) | Concentration in 2011 (ppmv) | Atmospheric lifetime (years) | Main human activity source | GWP** |
|---|---|---|---|---|---|
| Carbon dioxide (CO2) | 280 | 388.5 | ~100 | Fossil fuels, cement production, land use | 1 |
| Methane (CH4) | 0.715 | 1.87/1.748 | 12 | Fossil fuels, rice paddies, waste dumps, livestock | 25 |
| Nitrous oxide (N2O) | 0.27 | 0.323 | 114 | Fertilizers, combustion industrial processes | 298 |
| CFC-12 (CCL2F2) | 0 | 0.000533 | 100 | Liquid coolants, foams | 10,900 |
| CF-113 (CCl2CClF2) | 0 | 0.00000075 | 85 | n.a. | 6,130 |
| HFC 23 (CHF3) | 0 | 0.000018 | 270 | Electronics, refrigerants | 11,700 |
| HCFC-22 (CCl2F2) | 0 | 0.000218 | 12 | Refrigerants | 1,810 |
| HFC 134 (CF3CH2F) | 0 | 0.000035 | 14 | Refrigerants | 1,300 |
| HCFC-141b (CH3CCl2F) | 0 | 0.00000022 | 9.3 | n.a. | 725 |
| HCFC-142b (CH3CClF2) | 0 | 0.00000020 | 17.9 | n.a. | 2,310 |
| HFC 152 (CH3CHF2) | 0 | 0.0000039 | 1.4 | Industrial processes | 140 |
| Perfluoromethane (CF4) | 0.00004 | 0.00008* | 50,000 | Aluminum production | 6,500 |
| Perfluoroethane (C2F6) | 0 | 0.000003* | 10,000 | Aluminum production | 9,200 |
| Sulfur hexafluoride (SF6) | 0 | 0.00000712* | 3,200 | Dielectric fluid | 22,800 |
*Concentration in 2011.
**Global warming potentials (GWPs) measure the relative effectiveness of GHGs in trapping the Earth's heat.
Figure 1Global CO2 emissions from fossil fuel combustion and cement production [23].
Figure 2U.S. GHG Emissions Allocated to Economic Sectors [2].
Figure 3Three basic approaches of CO2 capture [29].
Figure 4Different technologies for CO2 separation [29].
Figure 5Schematic diagram of CO2 absorption pilot plant.
Various solvents suggested for CO2 separation.
| Group of solvents | Advantage | Disadvantage | Application | Reference |
|---|---|---|---|---|
| Physical | ||||
| Dimethyl ether of polyethylene glycol (Selexol) | (i) Require low energy for regeneration (less than 20% of the value for chemical absorbent) | (i) Dependent on temperature and pressure; therefore they are not suitable for post-combustion process | Natural gas sweetening | [ |
| Glycol | Capturing CO2 and H2S at higher concentration | |||
| Glycol carbonate | Separating CO2 from other gases | |||
| Methanol (Rectisol) | CO2 removal from various streams | |||
| Fluorinated solvent | (i) CO2 removal from various streams | |||
|
| ||||
| Chemical | ||||
| Alkanolamines: monoethanolamine (MEA), diethanolamine (DEA), and methyl diethanolamine (MDEA) | (i) React rapidly | (i) Low CO2 loading capacity | Important for removing acidic components from gas streams | [ |
| Amino acid and aqueous amino acid salt | (i) The possibility of adding a salt functional group. | Decreased performance in the presence of oxygen | Suggested for CO2 separation from flue gases | [ |
| Ammonia | (i) No degradation in the presence of SO2 and O2 in the flue gases | (i) Reversible at lower temperatures (not suitable for post-combustion) | Suggested for CO2 separation from flue gases | [ |
| Ionic liquid (IL) | (i) Very low vapor pressure | Increased viscosity with CO2 absorption | Suggested for CO2 separation from flue gases | [ |
| Aqueous piperazine (PZ) | (i) Fast absorption kinetics (CO2 absorption rate with aqueous PZ is more than double that of MEA) | Lower oxidative degradation of concentrated PZ (i.e., 4 times slower than MEA in the presence of the combination of Fe2+/Cr3+/Ni2+ and Fe2+/V5+) | (i) Effective for treating syngas at high temperatures | [ |
Figure 6Schematic layout of CO2 separation block based on the chilled ammonia process [92].
Adsorption capacity of chemical adsorbents for post-combustion CO2.
| Sorbent | Operating temperature (K) | Operating pressure (kPa) | CO2 capture capacity (mol CO2/kg sorbent) | Regeneration cycles, | CO2 capture capacity remained after | Reference |
|---|---|---|---|---|---|---|
| Mesoporous (MgO) | 298 | 101 | 1.8 | 3 | 100 | [ |
| CaO nanopods | 873 | 101 | 17.5 | 50 | 61.1 | [ |
| CaO derived from nanosized CaCO3 | 923 | 101 | 16.7 | 100 | 22.2 | [ |
| CaO-MgAl2O4 (spinel nanoparticles) | 923 | 101 | 9.1 | 65 | 84.6 | [ |
| Nano CaO/Al2O3 | 923 | 101 | 6.0 | 15 | 61.7 | [ |
| Lithium silicate nanoparticles | 883 | 101 | 5.77 | n.a. | n.a. | [ |
| Nanocrystalline Li2ZrO3 particles | 843 | 101 | 6.1 | 8 | 100 | [ |
| CaO/Al2O3 | 923 | 101 | 6.02 | n.a. | n.a. | [ |
| Lithium silicate | 993 | n.a. | 8.18 | n.a. | n.a. | [ |
| Lithium zirconate | 673 | 100 | 5.0 | n.a. | n.a. | [ |
| Lithium orthosilicate | 873 | 100 | 6.13 | n.a. | n.a. | [ |
| Calcium oxide | 873 | 100 | 17.3 | n.a. | n.a. | [ |
| Magnesium hydroxide | 473 | 1034 | 3.0 | n.a. | n.a. | [ |
| Mesoporous magnesium oxide | 373 | 100 | 2.27 | n.a. | n.a. | [ |
| Lithium Silicate nano particles | 873 | 101 | 5 | n.a. | n.a. | [ |
| HTI-HNa | 573 | 134 | 1.109 | 50 | 93.3 | [ |
Adsorption capacity of physical adsorbents for post-combustion CO2.
| Sorbent | Operating temperature (K) | Operating pressure (kPa) | CO2 capture capacity (mol CO2/kg sorbent) | Regeneration cycles, | CO2 capture capacity remained after | Reference |
|---|---|---|---|---|---|---|
| Activated carbon | 303 | 110 | 1.58 | n.a. | n.a. | [ |
| AC (4% KOH) | 303 | 30 | 0.55 | n.a. | n.a. | [ |
| AC (EDA + EtOH) | 303 | 30 | 0.53 | n.a. | n.a. | [ |
| AC (4% KOH + EDA + EtOH) | 303 | 30 | 0.64 | n.a. | n.a. | [ |
| NiO-ACs | 298 | 101 | 2.227 | n.a. | n.a. | [ |
| 13X | 393 | 15.198 | 0.7 | n.a. | n.a. | [ |
| 5A | 393 | 15.198 | 0.38 | n.a. | n.a. | [ |
| 4A | 393 | 15.198 | 0.5 | n.a. | n.a. | [ |
| WEG-592 | 393 | 15.198 | 0.6 | n.a. | n.a. | [ |
| APG-II | 393 | 15.198 | 0.38 | n.a. | n.a. | [ |
| Na-Y | 273 | 10.132 | 4.9 | n.a. | n.a. | [ |
| Na-X | 373 | 101.32 | 1.24 | 2 | n.a. | [ |
| NaKA | 373 | 101.32 | 3.88 | — | n.a. | [ |
| NaX-h | 323 | 101.32 | 2.52 | 2 | n.a. | [ |
| NaX-h | 373 | 101.32 | 1.37 | 2 | n.a. | [ |
| Na-X-c | 323 | 101.32 | 2.14 | 2 | n.a. | [ |
| Na-X-c | 373 | 101.32 | 1.41 | 2 | n.a. | [ |
| Cs-X-h | 323 | 101.32 | 2.42 | 2 | n.a. | [ |
| Cs-X-h | 373 | 101.32 | 1.48 | 2 | n.a. | [ |
| Cs-X-c | 323 | 101.32 | 1.76 | 2 | n.a. | [ |
| Cs-X-c | 373 | 101.32 | 1.15 | n.a. | n.a. | [ |
| MCM-41 | 298 | 100 | 0.62 | n.a. | n.a. | [ |
| MCM-41 (DEA) | 348 | 100 | 1.26 | n.a. | n.a. | [ |
| MCM-41 (50% PEI) | 348 | 100 | 2.52 | n.a. | n.a. | [ |
| Activated carbon | 303 | 30 | 0.35 | n.a. | n.a. | [ |
| MCM-41 (50% PEI) “molecular basket” | 348 | 100 | 2.95 | n.a. | n.a. | [ |
| PE-MCM-41 | 298 | 100 | 0.50 | n.a. | n.a. | [ |
| PE-MCM-41 (TRI) | 298 | 100 | 2.85 | n.a. | n.a. | [ |
| PE-MCM-41 (DEA) | 348 | 100 | 2.36 | n.a. | n.a. | [ |
| MCM-48 | 298 | 100 | 0.033 | n.a. | n.a. | [ |
| MCM-48 (APTS) | 298 | 100 | 0.639 | n.a. | n.a. | [ |
| MCM-41 | 298 | 100 | 0.62 | n.a. | n.a. | [ |
| Molecular basket' | 348 | 100 | 2.5 | 8 | 96.0 | [ |
| PE-MCM-41 (TRI) | 298 | 100 | 1.8 | 10 | 94.4 | [ |
| PE-MCM-41 (DEA) | 298 | 100 | 2.9 | 7 | 96.6 | [ |
| MWNT | 303 | 101 | 1.7 | 20 | n.a. | [ |
| Unmodified [(Cu3(btc)2]* | 298 | 1818 | 6.7 | n.a. | n.a. | [ |
| CNT@ (Cu3(btc)2) | 298 | 1818 | 13.52 | n.a. | n.a. | [ |
| MIL-101** | 298 | 1010 | 0.84 | n.a. | n.a. | [ |
| MWCNT@MIL-101 | 298 | 1010 | 1.35 | n.a. | n.a. | [ |
| MOF-2 | 298 | 4545 | 3.20 | n.a. | n.a. | [ |
| MOF-177 | 298 | 4545 | 33.5 | n.a. | n.a. | [ |
| Zr-MOFs | 273 | 988 | 8.1 | n.a. | n.a. | [ |
| Ca-Al LDH with ClO4 − | 406 | 1 | 3.55 | n.a. | n.a. | [ |
| Pd-GNP nanocomposite | 298 | 1111 | 5.1 | n.a. | n.a. | [ |
| f-GNP | 298 | 1111 | 4.3 | n.a. | n.a. | [ |
| Pd-GNP nanocomposite | 298 | 1111 | 4.5 | n.a. | n.a. | [ |
| f-GNP | 298 | 1111 | 3.8 | n.a. | n.a. | [ |
| Pd-GNP nanocomposite | 298 | 1111 | 4.1 | n.a. | n.a. | [ |
| f-GNP | 298 | 1111 | 3.3 | n.a. | n.a. | [ |
| Ceria-based oxides doped with 5% gallium (III) | 298 | 101 | 0.282 | n.a. | n.a. | [ |
| Amine modified layered double hydroxides (LDHs) | 298–353 | 101 | 0.74–1.75 | n.a. | n.a. | [ |
*Cu3(btc)2; btc: 1,3,5-benzene-tricarboxylate.
**MIL-101 or Cr3(F,OH)(H2O)2O[(O2C)C6H4(CO2)]3 ·nH2O (n ≈ 25) is one of the metal organic frameworks with Lewis acid sites that can be activated by removal of guest water molecules.
Figure 7Schematic diagrams of various adsorption cycles, (a) TSA, (b) PSA, (c) VSA, and (d) ESA; thin lines indicated operation streams in regenerated step.
Comparison between several adsorption cycles for CO2 separation process [166].
| Process | CO2 feed molar fraction | CO2 purity (%) | CO2 recovery (%) |
|---|---|---|---|
| PSA | 13 (O2) | 99.5 | 69 |
| TSA | 10 | 95 | 81 |
| TSA | 17 | n.a. | 40 |
| ESA | 10 | 23.33 | 92.57 |
| VSA | 15 | 90 | 90 |
| VSA | 17 | n.a. | 87 |
| 3-bed VSA | 12 | 90–95 | 60–70 |
| PSA/VSA | 20 | 58–63 | 70–75 |
| PSA/VSA | 15 (H2O) | 59 | 87 |
| VPSA | 17 | 99.5–99.8 | 34–69 |
| VPSA | 16 (O2) | 99 | 53–70 |
| PTSA | 10 | 99 | 90 |
| 2-bed-2-step PSA | n.a. | 18 | 90 |
| VTSA | 17 | n.a. | 97 |
Figure 8Novel CO2 cryogenic liquefaction and separation system [175].
Figure 9Schematic axial temperature and corresponding mass deposition profiles for the cryogenic; (a) capture, (b) recovery, and (c) cooling cycles [182].
Figure 10Plant layout showing the integration of the MCFC in a combined cycle, with cryogenic CO2 separation after oxygen combustion of the cell an anode exhaust [183].
Carbon dioxide and nitrogen gas permeability data for different membranes.
| Name | Feed pressure (atm) | Temperature (K) |
|
|
| Reference |
|---|---|---|---|---|---|---|
| Ion-exchanged zeolites membrane | ||||||
| Y (FAU) with | n.a. | 308 | n.a. | n.a. | 139 | [ |
| ZSM-5 (MFI) with | n.a. | n.a | n.a. | n.a. | 3 | [ |
| ZSM-5/polymeric silica | n.a. | 373 | 1140 | n.a. | [ | |
| Stainless steel support infiltrated with a eutectic molten carbonate mixture (Li/Na/K) | n.a. | 923 | 7780 | n.a. | 16 | [ |
| Y-type | n.a. | 303–403 | 35900–89800 | n.a. | 5 | [ |
| NaY | n.a. | 313 | 359000 | n.a. | 5 | [ |
| Li(20%)Y | n.a. | 308 | 210000 | n.a. | 3 | [ |
| K(30%)Y | n.a. | 308 | 269000 | n.a. | 9 | [ |
| K(62%)Y | n.a. | 313 | 150000 | n.a. | 6 | [ |
| Rb(38%)Y | n.a. | 313 | 150000 | n.a. | 3 | [ |
| Cs(32%)Y | n.a. | 313 | 59900 | n.a. | 2 | [ |
| 20% K2CO3, 80% Li2CO3 | n.a. | 798 | 2990 | n.a. | 4 | [ |
| MCM-48 | n.a. | n.a. | 10200 | n.a. | 0.8 | [ |
| PEI-modified MCM-48 | n.a. | 363 | 14100 | n.a. | 80 | [ |
| Chitosan | 1.75 | 295 | 100 | n.a. | 100 | [ |
| Swollen chitosan | 1.5 | 383 | 482 | n.a. | 250 | [ |
| Arginine salt-chitosan | 1.5 | 383 | 1500 | n.a. | 852 | [ |
|
| ||||||
| Polyacetylene | ||||||
| Polytrimethyl-prop-1-ynyl-silane | n.a. | 298 | 19000 | 1800 | 10.6 | [ |
| Poly-3,3-dimethyl-but-1-yne | n.a. | 298 | 560 | 43 | 13.0 | [ |
| Poly-1-(dimethyl-trimethylsilanylmethyl-silanyl)-propyne | n.a. | 298 | 310 | 21 | 14.8 | [ |
| Poly-1-[dimethyl-(2-trimethylsilanyl-ethyl)-silanyl]-propyne | n.a. | 298 | 150 | 14 | 10.7 | [ |
| Polytrimethyl-(2-prop-1-ynyl-phenyl)-silane | n.a. | 298 | 290 | 24 | 12.1 | [ |
| Poly-1-prop-1-ynyl-2-trifluoromethyl-benzene | n.a. | 298 | 130 | 7.3 | 17.8 | [ |
| Poly-dec-2-yne | n.a. | 298 | 130 | 14 | 9.3 | [ |
| Poly-1-chloro-dec-1-yne | n.a. | 298 | 170 | 16 | 10.6 | [ |
| Poly-1-chloro-oct-1-yne | n.a. | 298 | 130 | 11 | 11.8 | [ |
| Poly-1-chloro-hex-1-yne | n.a. | 298 | 180 | 10 | 18 | [ |
| Polyhexyl-dimethyl-prop-1-ynyl-silane | n.a. | 298 | 71 | 4.3 | 16.5 | [ |
| Polytrimethyl-(1-pentyl-prop-2-ynyl)-silane | n.a. | 298 | 120 | 8.7 | 13.8 | [ |
| Polyhexyl-dimethyl-(1-propyl-prop-2-ynyl)-silane | n.a. | 298 | 70 | 6.3 | 11.1 | [ |
| Polyprop-1-ynyl-benzene | n.a. | 298 | 25 | 2.2 | 11.4 | [ |
| Polybut-1-ynyl-benzene | n.a. | 298 | 40 | 4.5 | 8.9 | [ |
| Polyoct-1-ynyl-benzene | n.a. | 298 | 48 | 5.5 | 8.7 | [ |
| Polychloroethynyl-benzene | n.a. | 298 | 23 | 1.0 | 23.0 | [ |
| Poly-1-ethynyl-2-methyl-benzene | n.a. | 298 | 15 | 3.0 | 5.0 | [ |
| Polydimethyl-phenyl-(1-propyl-prop-2-ynyl)-silane | n.a. | 298 | 54 | 2.5 | 21.6 | [ |
|
| ||||||
| Polyarylene ether | ||||||
| 6FPT-6FBPA | 1.0 | 308 | 25.29 | 2.18 | 11.6 | [ |
| 6FPT-BPA 1.0 35 | 1.0 | 308 | 18.53 | 1.37 | 13.5 | [ |
| 6FPPy-6FBPA | 1.0 | 308 | 29.46 | 2.39 | 12.32 | [ |
| 6FPPy-BPA | 1.0 | 308 | 21.44 | 1.70 | 12.6 | [ |
|
| ||||||
| Fixed site carrier membrane (FSCM) | ||||||
| Polarix | 2.0 | 303 | 107 | n.a. | 50 | [ |
| PAAM-PVA/PS | 10 | 298 | 2.4 × 105 | n.a. | 80 | [ |
| PVAm/PVA blend | 1.45 | 298 | 2.12 × 106 | n.a. | 145 | [ |
| PEI/PVA | n.a. | 298 | 104 | n.a. | 230 | [ |
| PDMA/PS | 2 | 296 | 3 × 105 | n.a. | 53 | [ |
|
| ||||||
| Polyamine | ||||||
| PA12 | 10 | 308 | 120 | n.a. | 51 | [ |
| PA6 | 10 | 308 | 66 | n.a. | 56 | [ |
| Polyethyleneimine/polyvinyl butyral | 0.132 | 318 | 380 | n.a. | 32 | [ |
| Poly[(2-N,N-dimethyl) aminoethyl methacrylate] | 0.237 | 298 | 370 | n.a. | 111 | [ |
| Poly(vinylbenzyltrimethyl ammonium fluoride) | 0.224 | 296 | 113 | n.a. | 983 | [ |
| Polyethyleneimine/poly(vinyl alcohol) | 0.355 | 298 | 650 | n.a. | 235 | [ |
| PEI/PDMS/PEBA1657/PDMS | 5 | 298 | 1.57 × 106 | n.a. | 64 | [ |
|
| ||||||
| Polyarylate | ||||||
| BPA/IA | 10 | 308 | 5.4 | 0.24 | 22.5 | [ |
| BPA/tBIA | 10 | 308 | 24.2 | 1.20 | 20.2 | [ |
| HFBPA/IA | 10 | 308 | 19.1 | 1.11 | 17.2 | [ |
| HFBPA/tBIA | 10 | 308 | 56.9 | 3.88 | 14.7 | [ |
| PhTh/IA | 10 | 308 | 6.74 | 0.28 | 24.1 | [ |
| PhTh/tBIA | 10 | 308 | 23.8 | 1.09 | 21.8 | [ |
| FBP/IA | 10 | 308 | 12.4 | 0.57 | 12.4 | [ |
| FBP/tBIA | 10 | 308 | 36.8 | 1.93 | 19.1 | [ |
| TBBPA/IA | 10 | 308 | 4.93 | 0.18 | 27.4 | [ |
| TBBPA/tBIA | 10 | 308 | 21.5 | 0.90 | 23.9 | [ |
| TBHFBPA/IA | 10 | 308 | 25.6 | 1.07 | 23.9 | [ |
| TBHFBPA/tBIA | 10 | 308 | 85.1 | 4.47 | 19.0 | [ |
| TBPhTh/IA | 10 | 308 | 8.34 | 0.29 | 28.8 | [ |
| TBPhTh/tBIA | 10 | 308 | 30.6 | 1.28 | 23.9 | [ |
| TBFBP/IA | 10 | 308 | 20.4 | 0.70 | 29.1 | [ |
| TBFBP/tBIA | 10 | 308 | 69.5 | 2.94 | 23.6 | [ |
| DMBPA/IA | 10 | 308 | 1.24 | 0.063 | 19.7 | [ |
| DMBPA/Tbia | 10 | 308 | 8.0 | 0.39 | 20.5 | [ |
| TMBPA/IA | 10 | 308 | 12.0 | 0.58 | 20.7 | [ |
| TMBPA/tBIA | 10 | 308 | 44.6 | 2.52 | 17.7 | [ |
| DiisoBPA/IA | 10 | 308 | 5.16 | 0.27 | 19.1 | [ |
| DiisoBPA/tBIA | 10 | 308 | 16.1 | 1.08 | 14.9 | [ |
| DBDMBPA/IA | 10 | 308 | 5.45 | 0.22 | 24.8 | [ |
| PhAnth/IA | 10 | 308 | 9.0 | 0.36 | 25 | [ |
| PhAnth/tBIA | 10 | 308 | 25.9 | 1.35 | 19.2 | [ |
| FBP/IA | 10 | 308 | 12.4 | 0.57 | 21.8 | [ |
| FBP/tBIA | 10 | 308 | 36.8 | 1.93 | 19.1 | [ |
|
| ||||||
| Polycarbonates | ||||||
| PC | 1–10 | 308 | 6.0–6.8 | 0.289–0.32 | 21 | [ |
| TMPC | 1–10 | 308 | 17.58–18.6 | 1.0 | 18.6 | [ |
| TCPC | 1 | 308 | 6.66 | 0.36 | 18.5 | [ |
| TBPC | 1 | 308 | 4.23 | 0.182 | 23.2 | [ |
| HFPC | 10 | 308 | 24 | 1.6 | 15.0 | [ |
| TMHFPC | 10 | 308 | 111 | 7.4 | 15.0 | [ |
| NBPC | 10 | 308 | 9.1 | 0.47 | 19.4 | [ |
| PCZ | 10 | 308 | 2.2 | 0.105 | 21.0 | [ |
| PC-AP | 2 | 308 | 9.48 | 0.361 | 26.3 | [ |
| FBPC | 2 | 308 | 15.1 | 0.592 | 25.5 | [ |
|
| ||||||
| Polyethylene oxide | ||||||
| PEO | 7.8 | 298 | 8.1 | 0.07 | 140 | [ |
| PEO | 4.4–14.6 | 308–318 | 13–52 | 0.24–1 | 55 | [ |
| PEO-PBT | n.a. | 308 | 120 | 2 | 60 | [ |
| EO/EM/AGE (80/20/2) | n.a. | 308 | 773 | 16.8 | 46 | [ |
| EO/EM/AGE (77/23/2.3) | n.a. | 308 | 680 | 15.5 | 44 | [ |
| EO/EM/AGE (96/4/2.5) | n.a. | 308 | 580 | 12.1 | 48 | [ |
|
| ||||||
| Polyimides | ||||||
| Amine modified polyimide | 0.368 | 308 | 186 | n.a. | 38 | [ |
| PMDA-BAPHF | 6.8 | 308 | 11.8 | 0.66 | 17.8 | [ |
| PMDA-3BAPHF | 6.8 | 308 | 6.12 | 0.29 | 21.1 | [ |
| PMDA-4,4′-ODA | 6.8–10 | 308 | 1.14–2.7 | 0.049–0.1 | 23.3 | [ |
| PMDA-3,3′-ODA | 6.8–10 | 308 | 0.50–3.55 | 0.018–0.145 | 24.5–27.8 | [ |
| PMDA-MDA | 10 | 308 | 4.03 | 0.20 | 20.2 | [ |
| PMDA-IPDA | 10 | 308 | 29.7 | 1.50 | 19.8 | [ |
| PMDA-BAPHF | 10 | 308 | 17.6 | 0.943 | 18.7 | [ |
| PMDA-BATPHF | 10 | 308 | 24.6 | 1.50 | 16.4 | [ |
| BPDA-BAHF | 1–10 | 298–308 | 23–27.7 | 0.6–1.39 | 19.9–37.7 | [ |
| BPDA-mTrMPD | 10 | 308 | 137 | 8.42 | 16.3 | [ |
| BTDA-4,4-ODA | 10 | 308 | 0.625 | 0.0236 | 26.5 | [ |
| BTDA-BAPHF | 10 | 308 | 4.37 | 0.195 | 22.4 | [ |
| BTDA-BAHF | 10 | 308 | 10.1 | 0.45 | 22.4 | [ |
| BTDA-mTrMPD | 10 | 308 | 30.9 | 1.55 | 19.9 | [ |
| BTDA-BAFL | 1 | 298 | 15 | 0.39 | 38.5 | [ |
| PI | 10 | 308 | 2.00 | 0.063 | 31.7 | [ |
| oMeCat-durene | 1 | 303 | 27 | 0.83 | 33 | [ |
| mMeCat-durene | 1 | 303 | 20 | 0.59 | 34 | [ |
| DMeCat-durene | 1 | 303 | 63 | 2.05 | 31 | [ |
| mtBuCat-durene | 1 | 303 | 71 | 2.55 | 28 | [ |
| oMeptBuCat-durene | 1 | 303 | 67 | 2.5 | 27 | [ |
| TMeCat-durene | 1 | 303 | 200 | 8.1 | 25 | [ |
| mMetCat-MDA | 1 | 303 | 22 | 0.65 | 34 | [ |
| mtBuCat-MDA | 1 | 303 | 63 | 2.2 | 29 | [ |
| TMeCat-MDA | 1 | 303 | 110 | 3.8 | 30 | [ |
| TMeCat-TMB | 1 | 303 | 39 | 1.2 | 33 | [ |
| DBuCat-TMB | 1 | 303 | 95 | 4.9 | 19 | [ |
| mtBuCat-DMOB | 1 | 303 | 6.7 | 0.21 | 32 | [ |
| TMeCat-6FiPDA | 1 | 303 | 54 | 1.9 | 28 | [ |
| 6F | 3 | n.a. | 114 | 5.8 | 19.6 | [ |
| TMMPD | 3 | n.a. | 600 | 35.1 | 17.1 | [ |
| IMDDM | 3 | n.a. | 196 | 10.8 | 18.1 | [ |
| ODA | 3 | n.a. | 25 | 0.97 | 25.8 | [ |
| Matrimid 5218 | 10 | 308 | 6.5 | 0.25 | 25.6 | [ |
|
| ||||||
| 6FDA-based polyimides | ||||||
| 6FDA-pPDA | 10 | 308 | 15.3 | 0.80 | 19.12 | [ |
| 6FDA-pDiMPDA | 10 | 303 | 42.7 | 2.67 | 16.0 | [ |
| 6FDA-durene | 10 | 308 | 440 | 35.60 | 12.4 | [ |
| 6FDA-durene | 10 | 303 | 456 | 35.50 | 12.85 | [ |
| 6FDA-mPDA | 6.8–10 | 308 | 8.23–9.20 | 0.36–0.447 | 20.6–22.7 | [ |
| 6FDA-mMPDA | 6.8–10 | 303 | 40.1–42.5 | 2.12–2.24 | 17.9–20.1 | [ |
| 6FDA-mTrMPDA | 10 | 308 | 431 | 31.6 | 13.6 | [ |
| 6FDA-DATr | 6.8 | 303 | 28.63 | 1.31 | 21.9 | [ |
| 6FDA-DBTF | 6.8 | 308 | 21.64 | 1.17 | 18.5 | [ |
| 6FDA-PHDoeP | 6.8 | 303 | 8.59 | 4.50 | 1.91 | [ |
| 6FDA-PEPE | 6.8 | 308 | 6.88 | 0.255 | 27.0 | [ |
| 6FDA-PBEPE | 6.8 | 303 | 2.50 | 0.099 | 25.3 | [ |
| 6FDA-PMeaP | 6.8 | 308 | 2.41 | 0.086 | 28.0 | [ |
| 6FDA-3,4′ODA | 10 | 303 | 6.11 | 0.259 | 23.6 | [ |
| 6FDA-APAP | 10 | 308 | 10.7 | 0.473 | 22.6 | [ |
| 6FDA-pp′ODA | 10 | 303 | 16.7 | 0.733 | 22.8 | [ |
| 6FDA-BAPHF | 10 | 308 | 19.1 | 0.981 | 19.5 | [ |
| 6FDA-BATPHF | 10 | 303 | 22.8 | 1.30 | 17.5 | [ |
| 6FDA-BAHF | 10 | 308 | 51.2 | 3.11 | 16.5 | [ |
| 6FDA-1,5-NDA | 10 | 308 | 23 | 1.1 | 21 | [ |
| 6FDA-durene 24 h amidation | 10 | n.a. | 11.6 | 1.33 | 8.75 | [ |
| 6FDA-durene/mPDA (50/50) | 10 | n.a. | 84.6 | 5.18 | 16.4 | [ |
| 6FDA-durene/mPDA (50/50) 4 h amidation | 10 | n.a. | 54.9 | 3.38 | 16.2 | [ |
| 6FDA-durene/mPDA (50/50) 6 h amidation | 10 | n.a. | 49.1 | 3.27 | 15.0 | [ |
| 6FDA-durene/mPDA (50/50) 12 h amidation | 10 | n.a. | 46.0 | 2.94 | 15.6 | [ |
| 6FDA-durene/mPDA (50/50) 24 h amidation | 10 | n.a. | 36.0 | 2.06 | 17.5 | [ |
| 6FDA-durene/mPDA (50/50) 48 h amidation | 10 | n.a. | 24.5 | 1.38 | 17.8 | [ |
| 6FDA-FDA/HFBAPP (1/1) | 1.1 kg/cm2 | 303 | 465.0 | 19.9 | 23.4 | [ |
| 6FDA-ODA | 10 | 308 | 23 | 0.83 | 27.7 | [ |
| 6FDA-4,4-ODA | 6.8 | 303 | 22.0 | 0.94 | 23.4 | [ |
| 6FDA-MDA | 10 | 308 | 19 | 0.81 | 23.5 | [ |
| 6FDA-4BDAF | 6.8 | 303 | 19 | 0.98 | 19.4 | [ |
| 6FDA-3,3′-ODA | 6.8 | 308 | 2.1 | 0.10 | 21 | [ |
| 6FDA-3BDAF | 6.8 | 303 | 6.3 | 0.24 | 26.3 | [ |
| 6FDA-IPDA | 10 | 308–328 | 24.3–27.4 | 0.87–1.39 | 19.7–27.9 | [ |
| 6FDA-DAF | 10 | 308–328 | 19.5–21.3 | 0.81–1.15 | 18.5–24.1 | [ |
| PI-1 | 1 | 303 | 32 | 1.4 | 22.9 | [ |
| PI-3 | 1 | 303 | 360 | 16.5 | 21.8 | [ |
| PI-4 | 1 | 303 | 62 | 2.4 | 25.8 | [ |
| PI-5 | 1 | 303 | 190 | 7.3 | 26.0 | [ |
| 6FDA-BAFL | 1 | 298 | 98 | 3.3 | 29.7 | [ |
|
| ||||||
| Poly(phenylene oxide) | ||||||
| PPO (hollow fiber) | 4 | 308 | 106 | 21 | [ | |
| PPS | 1.5 | 308 | 1.60 | 0.046 | 34.8 | [ |
| PDMPO | 1.5 | 308 | 65.5 | 3.5 | 18.7 | [ |
| PDPPO | 1.5 | 308 | 39.9 | 1.5 | 26.6 | [ |
| PDMPO | 6.891 | 295 | 90.0 | 3.7 | 24.3 | [ |
| PDMPO (20.0% brominated) | 6.891 | 295 | 93.6 | 3.8 | 24.6 | [ |
| PDMPO (37.4% brominated) | 6.891 | 295 | 97.1 | 3.7 | 26.2 | [ |
| PDMPO (60.0% brominated) | 6.891 | 295 | 159.9 | 8.0 | 20.0 | [ |
|
| ||||||
| Polypyrrole | ||||||
| 6FDA-TAB | 10 | 308 | 54.0 | 2.6 | 20.8 | [ |
| 6FDA-TADPO | 10 | 308 | 27.6 | 1.2 | 23.0 | [ |
| BBL | 10 | 308 | 0.12 | 0.003 | 46.3 | [ |
|
| ||||||
| Polysulfones | ||||||
| PSF | 10 | 308 | 5.6 | 0.25 | 22.4 | [ |
| TMPSF | 10 | 308 | 21 | 1.06 | 19.8 | [ |
| HFPSF | 10 | 308 | 12 | 0.67 | 17.9 | [ |
| TMHFPSF | 10 | 308 | 72 | 4.0 | 18 | [ |
| PSF-F | 10 | 308 | 4.5 | 0.20 | 22.5 | [ |
| PSF-O | 10 | 308 | 4.3 | 0.20 | 21.5 | [ |
| PSF-P | 10 | 308 | 6.8 | 0.32 | 21.3 | [ |
| TMPSF-F | 10 | 308 | 5.5 | 0.61 | 9.0 | [ |
| TMPSF-P | 10 | 308 | 13.2 | 0.57 | 23.2 | [ |
| BIPSF | 10 | 308 | 5.6 | 0.24 | 23.3 | [ |
| TMBIPSF | 10 | 308 | 31.8 | 1.21 | 26.3 | [ |
| 1,5-NPSF | 10 | 308 | 1.6 | 0.057 | 28.1 | [ |
| 2,6-NPSF | 10 | 308 | 1.5 | 0.051 | 29.4 | [ |
| 2,7-NPSF | 10 | 308 | 1.8 | 0.074 | 24.3 | [ |
| DMPSF | 10 | 308 | 2.1 | 0.091 | 23.1 | [ |
| HMBIPSF | 10 | 308 | 25.5 | 1.2 | 23.3 | [ |
| DMPSF-Z | 10 | 308 | 1.4 | 0.057 | 24.6 | [ |
| PSF-AP | 2 | 308 | 8.12 | 0.278 | 29.2 | [ |
| FBPSF | 2 | 308 | 13.8 | 0.484 | 28.5 | [ |
| PSF-M | 1 | 308 | 2.8 | 0.11 | 25.5 | [ |
| TMPSF-M | 10 | 308 | 7.0 | 0.28 | 25.0 | [ |
| PSF-BPFL | 1 | 308 | 10 | 0.25 | 40 | [ |
| 3,4′-PSF | 1 | 308 | 1.5 | 0.066 | 22.7 | [ |
| 1,3-ADM PSF | 35 | 308 | 7.2 | 0.33 | 21.8 | [ |
| 2,2-ADM PSF | 35 | 308 | 9.5 | 0.46 | 20.6 | [ |
| PSF (6% Br, 92% C | 1 | 308 | 36.5 | 2.1 | 17.4 | [ |
| PSF (3% Br, 47% C | 1 | 308 | 18.5 | 1.24 | 14.9 | [ |
| PSF (21% Br, 77% C | 1 | 308 | 28.2 | 1.7 | 16.6 | [ |
| PSF (5% Br, 45% C | 1 | 308 | 16.4 | 0.9 | 18.2 | [ |
| PSF | 1 | 308 | 5.6 | 0.25 | 22.4 | [ |
| PSF- | 1 | 308 | 21 | 0.96 | 22.2 | [ |
| PSF- | 1 | 308 | 70 | 3.29 | 21.3 | [ |
| PSF-CH2-TMS | 1 | 308 | 18 | 0.95 | 18.9 | [ |
| EM3 | 1 | 308 | 29 | 1.3 | 22 | [ |
| EM2 | 1 | 308 | 6.2 | 0.24 | 26 | [ |
| EM1 | 1 | 308 | 4.8 | 0.16 | 30 | [ |
| SM3 (degree of substitution = 2.0) | 1 | 308 | 18 | 0.77 | 23 | [ |
| SM3 (degree of substitution = 1.0) | 1 | 308 | 10 | 0.38 | 26 | [ |
| SM1 | 1 | 308 | 5.1 | 0.17 | 30 | [ |
| PPSF | 1 | 308 | 3.2 | 0.10 | 32 | [ |
| RM3 | 1 | 308 | 27 | 1.9 | 14 | [ |
| RM2 | 1 | 308 | 6.7 | 0.60 | 11 | [ |
| RM1 | 1 | 308 | 6.9 | 0.61 | 11 | [ |
| HFPSF | 1 | 308 | 12.0 | 0.67 | 17.9 | [ |
| HFPSF- | 1 | 308 | 105 | 5.63 | 18.6 | [ |
| HFPSF- | 1 | 308 | 41 | 2.0 | 20 | [ |
| HFPSF- | 1 | 308 | 84 | 4.7 | 18 | [ |
| HFPSF-TMS | 1 | 308 | 110 | 6.3 | 18 | [ |
| TM6FPSF | 1 | 308 | 72 | 4.0 | 18 | [ |
| TM6FPSF- | 1 | 308 | 96 | 5.2 | 19 | [ |
| TMPSF-TMS | 1 | 308 | 32 | 1.51 | 21.3 | [ |
| TMPSF- | 1 | 308 | 66.3 | 3.07 | 21.6 | [ |
| TMPSF-HBTMS | 1 | 308 | 72 | 3.36 | 21.4 | [ |
|
| ||||||
| Other membranes | ||||||
| HQDPA-PDA | 7 | 303 | 0.598 | 0.016 | 37.4 | [ |
| HQDPA-PDA | 7 | 373 | 1.70 | 0.111 | 15.3 | [ |
| HQDPA-DBA | 7 | 303 | 0.683 | 0.015 | 45.5 | [ |
| HQDPA-DBA | 7 | 373 | 2.10 | 0.125 | 16.8 | [ |
| HQDPA-MDBA | 7 | 303 | 1.18 | 0.034 | 34.7 | [ |
| HQDPA-MDBA | 7 | 373 | 2.37 | 0.160 | 14.8 | [ |
| HQDPA-EDBA | 7 | 303 | 2.26 | 0.077 | 29.4 | [ |
| HQDPA-EDBA | 7 | 373 | 4.18 | 0.292 | 14.3 | [ |
| 12H | 5 | 308 | 4.6 | 0.21 | 21.9 | [ |
| 6H6F | 5 | 308 | 8.6 | 0.44 | 19.5 | [ |
| 6F6H | 5 | 308 | 8.9 | 0.42 | 21.2 | [ |
| 12F | 5 | 308 | 12.9 | 0.76 | 17.0 | [ |
| PBK | 10 | 308 | 3.3 | 0.13 | 25.4 | [ |
| PBK-S | 10 | 308 | 3.27 | 0.11 | 29.7 | [ |
| PBSF | 10 | 308 | 10.8 | 0.47 | 23.0 | [ |
| PES/PI | 4 | 308 | 1.15 × 105 | n.a. | 30 | [ |
| PPES | n.a. | 273 | 0.92 | 0.027 | 34 | [ |
| PPESK | n.a. | 273 | 0.75 | 0.042 | 18 | [ |
| 20 percent DEA immobilized in 25.4 | 0.16–1.67 | 298 | 974–4825 | n.a. | 56–276 | [ |
|
| ||||||
| Copolymers and polymer blend | ||||||
| PEBA 2533 (hollow fiber) | 6.8 | 273 | 260 | n.a. | 32 | [ |
| PEBA/PSF composite | 3.4 | 273 | 6.1 × 105 | n.a. | 30 | [ |
| COPNA | n.a. | 373 | 2990 | n.a. | 14 | [ |
| Pebax | n.a. | 303 | 73 | n.a. | 15.6 | [ |
| Pebax/PEG10 | n.a. | 303 | 75 | n.a. | 15.8 | [ |
| Pebax/PEG20 | n.a. | 303 | 80 | n.a. | 15.9 | [ |
| Pebax/PEG30 | n.a. | 303 | 105 | n.a. | 15.1 | [ |
| Pebax/PEG40 | n.a. | 303 | 132 | n.a. | 15.1 | [ |
| Pebax/PEG50 | n.a. | 303 | 151 | n.a. | 15.5 | [ |
| Pebax/PEG-DME10 | n.a. | 303 | 123 | n.a. | 44 | [ |
| Pebax/PEG-DME20 | n.a. | 303 | 206 | n.a. | 45 | [ |
| Pebax/PEG-DME30 | n.a. | 303 | 300 | n.a. | 46 | [ |
| Pebax/PEG-DME40 | n.a. | 303 | 440 | n.a. | 42 | [ |
| Pebax/PEG-DME50 | n.a. | 303 | 606 | n.a. | 43 | [ |
| 6FDA-TAB | 10 | 308 | 54.0 | 2.8 | 19.3 | [ |
| 6FDA/PMDA-TAB (50 : 50) | 10 | 308 | 15.8 | 0.70 | 22.6 | [ |
| 6FDA/PMDA-TAB (25 : 75) | 10 | 308 | 3.13 | 0.098 | 31.9 | [ |
| 6FDA/PMDA-TAB (10/90) | 10 | 308 | 1.11 | 0.036 | 30.8 | [ |
| 6FDA-TAB/DAM (75/25) | 3 | 308 | 73.7 | 3.1 | 23.8 | [ |
| 6FDA-TAB/DAM (50/50) | 3 | 308 | 155 | 6.6 | 23.5 | [ |
| 6FDA-DAM | 3 | 308 | 370 | 29.5 | 12.5 | [ |
| 6FDA/TMPDA | n.a. | 308 | 400 | 23.5 | 17.02 | [ |
| 6FDA/PMDA (1 : 6)-TMMDA (CH2Cl2 cast) | 10 | 308 | 187 | 11.7 | 16.0 | [ |
| 6FDA/PMDA (1 : 6)-TMMDA (NMP cast) | 10 | 308 | 144 | 8.76 | 16.4 | [ |
| 6FDA/PMDA (1 : 6)-TMMDA (DMF cast) | 10 | 308 | 88.6 | 5.16 | 17.2 | [ |
| MDI-BPA/PEG (75) | 2 | 308 | 31 | 0.70 | 44 | [ |
| MDI-BPA/PEG (80) | 2 | 308 | 48 | 1.0 | 47 | [ |
| MDI-BPA/PEG (85) | 2 | 308 | 59 | 1.20 | 49 | [ |
| L/TDI (20)-BPA/PEG (90) | 2 | 308 | 47 | 0.92 | 51 | [ |
| L/TDI (40)-BPA/PEG (85) | 2 | 308 | 35 | 0.72 | 48 | [ |
| IPA-ODA/PEO3 (80) | 2 | 308 | 58 | 1.1 | 53 | [ |
| BPDA-pp′ODA | n.a. | 303 | 18000 | n.a. | 31 | [ |
| BPDA-ODA/DAT (oxidized) | n.a. | 308 | 599 | n.a. | 40 | [ |
| BPDA-ODA/DABA/PEO1 (75) | 2 | 308 | 2.7 | 0.048 | 56 | [ |
| BPDA-mDDS/PEO1 (80) | 2 | 308 | 3.8 | 0.066 | 58 | [ |
| BPDA-ODA/DABA/PEO2 (70) | 2 | 308 | 14 | 0.25 | 57 | [ |
| BPDA-ODA/DABA/PEO2 (80) | 2 | 308 | 36 | 0.64 | 56 | [ |
| BPDA-ODA/PEO3 (75) | 2 | 308 | 75 | 1.4 | 52 | [ |
| BPDA-mDDS/PEO3 (75) | 2 | 308 | 72 | 1.4 | 53 | [ |
| BPDA-mPD/PEO4 (80) | 2 | 308 | 81 | 1.5 | 54 | [ |
| BPDA-ODA/PEO4 (80) | 2 | 308 | 117 | 2.3 | 51 | [ |
| PMDA-ODA/DABA/PEO1 (80) | 2 | 308 | 14 | 0.27 | 52 | [ |
| PMDA-ODA/PEO2 (75) | 2 | 308 | 40 | 0.74 | 54 | [ |
| PMDA-mPD/PEO3 (80) | 2 | 308 | 99 | 2.0 | 50 | [ |
| PMDA-APPS/PEO3 (80) | 2 | 308 | 159 | 3.1 | 51 | [ |
| PMDA-APPS/PEO4 (70) | 2 | 308 | 136 | 2.6 | 53 | [ |
| PMDA-mPD/PEO4 (80) | 2 | 308 | 151 | 2.9 | 52 | [ |
| PMDA-ODA/PEO4 (80) | 2 | 308 | 167 | 3.2 | 52 | [ |
| PMDA-pDDS/PEO4 (80) | 2 | 308 | 238 | 4.9 | 49 | [ |
| PMDA/BTDA-BAFL (50 : 50) | 1 | 298 | 43 | 1.3 | 33 | [ |
| PMDA/BTDA–BAFL (90 : 10) | 1 | 298 | 130 | 3.8 | 34 | [ |
| BPDA-BAFL/HMDA (50 : 50) | 1 | 298 | 0.54 | 0.014 | 39 | [ |
| PPES | n.a. | 298 | 0.92 | 0.027 | 34 | [ |
| PPES/PPEK (3 : 1) | n.a. | 298 | 2.94 | 0.074 | 40 | [ |
| PPES/PPEK (1 : 1) | n.a. | 298 | 4.12 | 0.089 | 46 | [ |
| PPES/PPEK (1 : 3) | n.a. | 298 | 2.06 | 0.026 | 39 | [ |
| PPES/PPEK (1 : 4) | n.a. | 298 | 1.77 | 0.052 | 34 | [ |
| PPEK 18 | n.a. | 298 | 0.75 | 0.042 | 18 | [ |
| HQDPA-DPA/MDPA | 7 | 303 | 0.957 | 0.023 | 41.2 | [ |
| HQDPA-DPA/MDPA | 7 | 373 | 2.34 | 0.147 | 15.9 | [ |
| HQDPA-DPA/EDPA | 7 | 303 | 1.334 | 0.036 | 37.6 | [ |
| HQDPA-DPA/EDPA | 7 | 373 | 3.25 | 0.207 | 15.7 | [ |
| PI | 10 | 308 | 2.00 | 0.063 | 31.7 | [ |
| PI/10PS | 10 | 308 | 2.33 | 0.085 | 27.4 | [ |
| PI/15PS | 10 | 308 | 2.32 | 0.09 | 25.8 | [ |
| PI/20PS | 10 | 308 | 2.90 | 0.91 | 3.19 | [ |
| PI/25PS | 10 | 308 | 4.29 | 0.91 | 4.71 | [ |
| PI/10PSVP | 10 | 308 | 3.58 | 0.13 | 28.4 | [ |
| PI/15PSVP | 10 | 308 | 3.71 | 0.14 | 26.5 | [ |
| PI/20PSVP | 10 | 308 | 5.65 | 0.15 | 38.4 | [ |
| PI/25PSVP | 10 | 308 | 6.55 | 1.55 | 4.31 | [ |
| NTDA-BDSA (30)/CARDO/ODA | 3 | 303 | 70 | 1.7 | 41 | [ |
| NTDA-BDSA (30)/CARDO] | 3 | 303 | 164 | 4.5 | 36 | [ |
| NTDA-BDSA (30)/BAPHF | 3 | 303 | 23 | 0.64 | 36 | [ |
| NTDA-BDSA (30)/ODA | 3 | 303 | 5.2 | 0.1 | 52 | [ |
| 6FDA-FDA/HFBAPP (1/1) | 1.1 kg/cm2 | 303 | 465 | 19.9 | 23.4 | [ |
| 6FDA-durene/pPDA (80/20) | 10 | 308 | 230 | 16.88 | 13.62 | [ |
| 6FDA-durene/pPDA (50/50) | 10 | 308 | 126 | 7.74 | 16.28 | [ |
| 6FDA-durene/pPDA (20/80) | 10 | 308 | 59.26 | 2.81 | 21.09 | [ |
| 6FDA-durene/3,3′-DDS (75/25) | 10 | 308 | 84.7 | 5.91 | 14.3 | [ |
| 6FDA-durene/3,3′-DDS (50/50) | 10 | 308 | 19.8 | 1.09 | 18.2 | [ |
| 6FDA-durene/3,3′-DDS (25/75) | 10 | 308 | 5.12 | 0.26 | 19.7 | [ |
| 6FDA-3,3′-DDS | 10 | 308 | 1.84 | 0.08 | 22.7 | [ |
| 6FDA-6FpDA-DABA-12.5 | 4 | 308 | 34.0 | 2.01 | 16.9 | [ |
| 6FDA-6FpDA–DABA-12.5 annealed | 4 | 308 | 70.8 | 4.50 | 15.7 | [ |
| 6FDA-6FpDA-DABA-12.5 (22.5% TMOS) | 4 | 308 | 30.9 | 1.70 | 18.2 | [ |
| 6FDA-6FpDA-DABA-12.5 (22.5% TMOS) annealed | 4 | 308 | 47.6 | 3.16 | 15.1 | [ |
| 6FDA-6FpDA-DABA-12.5 (15.0% MTMOS) | 4 | 308 | 44.0 | 2.53 | 17.4 | [ |
| 6FDA-6FpDA-DABA-12.5 (15.0% MTMOS) annealed | 4 | 308 | 110 | 7.07 | 15.6 | [ |
| 6FDA-6FpDA-DABA-12.5 (15.0% PTMOS) 4 35 | 4 | 308 | 32.3 | 1.80 | 17.9 | [ |
| 6FDA-6FpDA-DABA-12.5 (15.0% PTMOS) annealed | 4 | 308 | 91.8 | 5.59 | 16.4 | [ |
| 6FDA-6FpDA-DABA-12.5 (22.5% PTMOS) | 4 | 308 | 30.7 | 1.88 | 16.3 | [ |
| 6FDA-6FpDA-DABA-12.5 (22.5% PTMOS) annealed | 4 | 308 | 90.9 | 5.87 | 15.5 | [ |
| 6FDA-6FpDA-DABA-25 | 4 | 308 | 20.3 | 1.20 | 16.9 | [ |
| 6FDA-6FpDA-DABA-25 annealed | 4 | 308 | 77.3 | 4.85 | 15.9 | [ |
| 6FDA-6FpDA-DABA-25 (22.5% TMOS) | 4 | 308 | 15.7 | 1.06 | 14.8 | [ |
| 6FDA-6FpDA-DABA-25 (22.5% TMOS) annealed | 4 | 308 | 79.8 | 4.87 | 16.4 | [ |
| 6FDA-6FpDA-DABA-25 (15.0% MTMOS) | 4 | 308 | 16.6 | 1.07 | 15.5 | [ |
| 6FDA-6FpDA-DABA-25 (15.0% MTMOS) annealed | 4 | 308 | 81.1 | 5.07 | 16.0 | [ |
| 6FDA–6FpDA-DABA-25 (22.5% MTMOS) | 4 | 308 | 16.6 | 1.07 | 15.5 | [ |
| 6FDA-6FpDA-DABA-25 (22.5% MTMOS) annealed | 4 | 308 | 60.1 | 3.837 | 15.7 | [ |
| 6FDA-6FpDA-DABA-25 (15.0% PTMOS) | 4 | 308 | 18.4 | 0.94 | 19.6 | [ |
| 6FDA-6FpDA-DABA-25 (15.0% PTMOS) annealed | 4 | 308 | 104 | 6.25 | 16.6 | [ |
| 6FDA-6FpDA-DABA-25 (22.5% PTMOS) | 4 | 308 | 19.1 | 0.98 | 19.5 | [ |
| 6FDA-6FpDA-DABA-25 (22.5% PTMOS) annealed | 4 | 308 | 104 | 6.25 | 16.6 | [ |
| Poly(5 : 5 BPA/BN) | 5 | 308 | 5.71 | 0.19 | 30.1 | [ |
| Poly(7 : 3 BPA/BN) | 5 | 308 | 4.62 | 0.16 | 28.9 | [ |
|
| ||||||
| Cross-linking polymers | ||||||
| Poly(ethylene oxide-co-epichlorohydrin) (1 : 1) 1.1% | 300 | 298 | 15.0 | 2.3 | 6.52 | [ |
| Poly(ethylene oxide-co-epichlorohydrin) (1 : 1) 2% | 300 | 298 | 14.9 | 1.0 | 14.9 | [ |
| Poly(ethylene oxide-co-epichlorohydrin) (1 : 1) 5% | 300 | 298 | 16.1 | 0.5 | 32.2 | [ |
| DM14/MM9 (100/0) | 0.967 | 298 | 45 | 0.66 | 68 | [ |
| DM14/MM9 (100/0) | 0.967 | 323 | 107 | 2.8 | 38 | [ |
| DM14/MM9 (90/10) | 0.967 | 298 | 62 | 0.90 | 69 | [ |
| DM14/MM9 (90/10) | 0.967 | 323 | 133 | 3.4 | 39 | [ |
| DM14/MM9 (70/30) | 0.967 | 298 | 96 | 1.5 | 66 | [ |
| DM14/MM9 (70/30) | 0.967 | 323 | 195 | 5.4 | 36 | [ |
| DM14/MM9 (50/50) | 0.967 | 298 | 144 | 2.25 | 64 | [ |
| DM14/MM9 (50/50) | 0.967 | 323 | 260 | 7.2 | 36 | [ |
| DM14/MM9 (30/70) | 0.967 | 298 | 210 | 3.3 | 63 | [ |
| DM14/MM9 (30/70) | 0.967 | 323 | 350 | 10.6 | 33 | [ |
| DB30/MM9 (100/0) | 0.967 | 298 | 93 | 1.5 | 63 | [ |
| DB30/MM9 (100/0) | 0.967 | 323 | 200 | 5.7 | 35 | [ |
| DB30/MM9 (90/10) | 0.967 | 298 | 105 | 1.6 | 64 | [ |
| DB30/MM9 (90/10) | 0.967 | 323 | 210 | 5.8 | 36 | [ |
| DB30/MM9 (70/30) | 0.967 | 298 | 141 | 2.1 | 67 | [ |
| DB30/MM9 (70/30) | 0.967 | 323 | 270 | 7.7 | 35 | [ |
| DB30/MM9 (50/50) | 0.967 | 298 | 179 | 2.9 | 62 | [ |
| DB30/MM9 (50/50) | 0.967 | 323 | 330 | 9.7 | 34 | [ |
| DB30/MM9 (30/70) | 0.967 | 298 | 250 | 4.2 | 60 | [ |
| DB30/MM9 (30/70) | 0.967 | 323 | 410 | 12.4 | 33 | [ |
| DM9/MM9 (90/10) | 0.967 | 298 | 18.3 | 0.3 | 68 | [ |
| DM9/MM9 (90/10) | 0.967 | 323 | 51 | 1.3 | 38 | [ |
| DM23/MM9 (90/10) | 0.967 | 298 | 145 | 2.2 | 66 | [ |
| DM23/MM9 (90/10) | 0.967 | 323 | 290 | 7.6 | 38 | [ |
| DB10/MM9 (90/10) | 0.967 | 298 | 6.7 | 0.11 | 61 | [ |
| DB10/MM9 (90/10) | 0.967 | 323 | 27 | 0.79 | 34 | [ |
| DB69/MM9 (90/10) (cooling) | 0.967 | 298 | 240 | 4.3 | 56 | [ |
| DB69/MM9 (90/10) (cooling) | 0.967 | 323 | 510 | 14.2 | 36 | [ |
| DB69/MM9 (90/10) (heating) | 0.967 | 298 | 98 | 1.6 | 62 | [ |
| DB69/MM9 (90/10) (heating) | 0.967 | 323 | 400 | 11.4 | 35 | [ |
| DM14/MM23 (30/70) (cooling) | 0.967 | 298 | 240 | 3.9 | 62 | [ |
| DM14/MM23 (30/70) (cooling) | 0.967 | 323 | 420 | 12 | 35 | [ |
| DM14/MM23 (30/70) (heating) | 0.967 | 298 | 250 | 4.0 | 62 | [ |
| Matrimid 5218 | 10 | 308 | 6.5 | 0.25 | 25.6 | [ |
| Matrimid 5218, 1-day cross-linking | 10 | 308 | 7.4 | 0.29 | 25.6 | [ |
| Matrimid 5218, 3-day cross-linking | 10 | 308 | 6.0 | 0.24 | 25.2 | [ |
| Matrimid 5218, 7-day cross-linking | 10 | 308 | 5.1 | 0.21 | 24.6 | [ |
| Matrimid 5218, 14-day cross-linking | 10 | 308 | 4.7 | 0.19 | 24.1 | [ |
| Matrimid 5218, 21-day cross-linking | 10 | 308 | 3.4 | 0.15 | 22.2 | [ |
| Matrimid 5218, 32-day cross-linking | 10 | 308 | 1.9 | 0.13 | 15.0 | [ |
| 6FDA-durene, 5 min cross-linked | 10 | 308 | 136 | 11.1 | 12.3 | [ |
| 6FDA-durene, 10 min cross-linked | 10 | 308 | 91.8 | 6.53 | 14.1 | [ |
| 6FDA-durene, 15 min cross-linked | 10 | 308 | 70.0 | 6.05 | 11.6 | [ |
| 6FDA-durene, 30 min cross-linked | 10 | 308 | 30.3 | 2.87 | 10.6 | [ |
| 6FDA-durene, 60 min cross-linked | 10 | 308 | 2.14 | 0.40 | 5.35 | [ |
*Permeability.
Comparison between various technologies used for CO2 capture.
| Technology | Advantages | Disadvantages | Scale |
|---|---|---|---|
| Absorption | (i) React rapidly | (i) Equipment corrosion | Industrial |
|
| |||
| Adsorption | (i) Low energy consumption and cost of CO2 capture | Low adsorption capacities (in flue gases conditions) | Pilot |
|
| |||
| Cryogenic distillation | (i) Liquid CO2 production | Require large amount of energy | Pilot |
|
| |||
| Membrane separation | (i) Clean and simple process | Require high energy for post-combustion CO2 capture | Experimental |